-
Today’s Watch List: Aratana Therapeutics (NASDAQ:PETX), Smith Micro Software Inc. (NASDAQ:SMSI), RXi Pharmaceuticals Corporation (NASDAQ:RXII), OmniVision Technologies (NASDAQ:OVTI), Gray Television (NYSE:GTN)
On Wednesday shares of Aratana Therapeutics, Inc. (NASDAQ:PETX) closed at $12.84. Company’s EPS growth for next 5 years is recorded as 15.00%. On May 04, Traverse Biosciences announced that it has executed a $250,000 cooperative research and development agreement (CRADA) with Aratana Therapeutics Inc. (NASDAQ:PETX) to advance the development of TRB-N0224 for the treatment and…
-
Don’t Miss: Exxon Mobil Corporation (NYSE:XOM), Aratana Therapeutics (NASDAQ:PETX), Citigroup Inc. (NYSE:C), First Financial Northwest (NASDAQ:FFNW), Mitsubishi UFJ Financial (NYSE:MTU)
On Wednesday shares of Exxon Mobil Corporation (NYSE:XOM) closed at $87.87. Company’s sales growth for last 5 years was 5.50% and EPS growth for next 5 years is recorded as -2.40%. Exxon Mobil Corporation (NYSE:XOM) on Wednesday raised its quarterly payout 6 percent, a move that underscores the world’s largest publicly traded oil company’s commitment…
-
Top Wall Street Stories: Aratana Therapeutics (NASDAQ:PETX), Juniper Networks (NYSE:JNPR), Trinity Industries Inc. (NYSE:TRN), Federated Investors (NYSE:FII), Freescale Semiconductor (NYSE:FSL)
On Thursday shares of Aratana Therapeutics, Inc. (NASDAQ:PETX) closed at $16.29. Company’s EPS growth for next 5 years is recorded as 15.00%. Aratana Therapeutics, Inc. (NASDAQ:PETX) announced that it will present at the Bank of America Merrill Lynch 2015 Health Care Conference to be held May 12-14, 2015, at the Encore at the Wynn in…
-
Hot Stocks: RXi Pharmaceuticals Corporation (NASDAQ:RXII), Aratana Therapeutics (NASDAQ:PETX), Ericsson (NASDAQ:ERIC), Luby’s (NYSE:LUB), EMC Corporation (NYSE:EMC)
On Tuesday shares of RXi Pharmaceuticals Corporation (NASDAQ:RXII) closed at $0.72. On March 27, RXi Pharmaceuticals Corporation (NASDAQ:RXII) and privately-held MirImmune LLC, announced that they have entered into an exclusive license agreement to RXi’s novel and proprietary sd-rxRNA® technology for use in developing innovative cell-based cancer immunotherapies. The collaboration has the potential to result in…
-
Eye Catching Stocks: Semler Scientific Inc (NASDAQ:SMLR), Aratana Therapeutics (NASDAQ:PETX), FireEye (NASDAQ:FEYE), JA Solar Holdings (NASDAQ:JASO), KMG Chemicals (NYSE:KMG)
On Thursday shares of Semler Scientific Inc (NASDAQ:SMLR) closed at $4.77. Semler Scientific, Inc. (Nasdaq: SMLR) announced receipt of 510(k) marketing clearance from the U.S. Food and Drug Administration for its next generation peripheral artery disease (PAD) testing system. Aratana Therapeutics, Inc. (NASDAQ:PETX) in last trading activity moved up 1.93% to close at $19.04. Company…
-
Active Watch List: eBay Inc. (NASDAQ:EBAY), Aratana Therapeutics (NASDAQ:PETX), Statoil ASA (NYSE:STO), BlackBerry Ltd (NASDAQ:BBRY), The Cato Corporation (NYSE:CATO)
On Tuesday shares of eBay Inc. (NASDAQ:EBAY) closed at $59.49. Company’s sales growth for last 5 years was 15.50% and EPS growth for next 5 years is recorded as 10.88%. eBay Inc. (NASDAQ:EBAY)’s new auction site in partnership with Sotheby’s is set to have its first auction on April 1. Aratana Therapeutics, Inc. (NASDAQ:PETX) in…
-
Traders Alert: Resonant Inc. (NASDAQ:RESN), Aratana Therapeutics (NASDAQ:PETX), Finisar Corp. (NASDAQ:FNSR), Cypress Semiconductor Corporation (NASDAQ:CY), Tremor Video (NYSE:TRMR)
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Resonant Inc. (NASDAQ:RESN) concerning possible violations of federal securities laws. The investigation is focused on the Company’s operations and financial prospects. On Monday shares of Resonant Inc. (NASDAQ:RESN) closed at $11.03. Aratana Therapeutics (NASDAQ:PETX) had its target price…
-
Investors Should Watch: Facebook Inc (NASDAQ:FB), Imperva Inc. (NYSE:IMPV), Aratana Therapeutics (NASDAQ:PETX), B&G Foods Inc. (NYSE:BGS), Baytex Energy Corp. (NYSE:BTE)
Facebook Inc. (NASDAQ:FB) urged a California federal judge on 18 February to ax Mobile-Plan-It’s case claiming Facebook infringes a patent on electronic proxy communications, arguing the patent is invalid under the U.S. Supreme Court’s Alice ruling because it simply computerizes a communication style as old as Cyrano de Bergerac. On Friday shares of Facebook Inc…
-
Investors Are Eying: Macrocure (NASDAQ:MCUR), EMC Corporation (NYSE:EMC), Aratana Therapeutics (NASDAQ:PETX), Intrawest Resorts Holdings (NYSE:SNOW), Sabre Corporation (NASDAQ:SABR)
Macrocure Ltd. (NASDAQ:MCUR) announced that Mark Page, a Managing Director at Credit Suisse (NYSE:CS) in New York, joined Macrocure as Chief Financial Officer effective February 10, 2015. On Tuesday shares of Macrocure Ltd. (NASDAQ:MCUR) closed at $11.00. EMC Corporation (NYSE:EMC) has been given an “A+” credit rating by analysts at Morningstar. The investment research firm’s…
-
Stocks Gaining Momentum: SandRidge Energy (NYSE:SD), Outerwall Inc. (NASDAQ:OUTR), Peapack-Gladstone Financial Corp. (NASDAQ:PGC), Aratana Therapeutics (NASDAQ:PETX), Movado Group (NYSE:MOV)
SandRidge Energy, Inc. (NYSE: SD) announced the appointment of J. Mike Stice to the board of directors. On Friday shares of SandRidge Energy, Inc. (NYSE:SD) closed at $2.19. Company’s sales growth for last 5 years was 10.90% and EPS growth for next 5 years is recorded as 30.90%. Outerwall Inc. (NASDAQ: OUTR) announced that on…